Mode
Text Size
Log in / Sign up
Phase 4 Completed N=104 Randomized Treatment

Comparing the Effectiveness of Individual vs. Household Treatment for Scabies in Lambaréné, Gabon

Scabies · Households
Source: ClinicalTrials.gov NCT04205669 ↗
Enrolled (actual)
104
Serious AEs
0.0%
Results posted
Nov 2020
Primary outcomePrimary: Number of Participants With Clinical Cure — 20; 33 Participants
◆ Published Evidence
Emerging ▲ Trending
14citations · ~2 / year
A randomized controlled trial comparing the effectiveness of individual versus household treatment for Scabies in Lambaréné, Gabon.
PLoS neglected tropical diseases · 2020 · Open access · Likely link

Summary

It is unclear whether individual treatment of scabies is similarly effective compared to household treatment. This study therefore compares these two treatment strategies with topical benzyl benzoate for treating scabies in Lambaréné and surroundings in Gabon. Subjects presenting with uncomplicated scabies are randomized into either the Individual Treatment group, where only the affected subjects receive treatment, or the Household Treatment group, where all family members are treated in parallel to the affected subjects regardless of signs and symptoms. The primary endpoint is clinical cure after 28 days; the secondary endpoint is the proportion of affected household members per household after 28 days.

Linked Publications

  • A randomized controlled trial comparing the effectiveness of individual versus household treatment for Scabies in Lambaréné, Gabon.
    PLoS neglected tropical diseases · 2020 · 14 citations · Open access · Likely link

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Clinical Cure
20; 33
SECONDARY
Proportion of Affected Household Members Per Household

Eligibility Criteria

Inclusion Criteria

  • diagnosed with active, uncomplicated scabies
  • no known hypersensitivity or allergy against benzyl benzoate

Exclusion Criteria

  • hypersensitivity or allergy against benzyl benzoate
  • severe superinfection of scabies lesions
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04205669) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search